Prelude Therapeutics, Inc. (PRLD)
3.46
+0.01
(+0.29%)
USD |
NASDAQ |
Apr 02, 16:00
3.47
+0.01
(+0.29%)
After-Hours: 20:00
Prelude Therapeutics Shareholders Equity (Quarterly) : 68.64M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Incyte Corp. | 5.167B |
| Immunome, Inc. | 634.34M |
| Sana Biotechnology, Inc. | 160.88M |
| Definitive Healthcare Corp. | 281.11M |
| Moderna, Inc. | 8.65B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 141.32M |
| Total Liabilities (Quarterly) | 72.68M |
| Debt to Equity Ratio | 0.2592 |
| Current Ratio | 1.994 |
| Net Debt Paydown Yield | 0.04% |